Biography and Research Information
OverviewAI-generated summary
Adam S. Morgenthau's research investigates cardiac and pulmonary manifestations of sarcoidosis, with a focus on utilizing advanced imaging techniques and artificial intelligence. His work includes systematic reviews on artificial intelligence applications in interstitial lung disease analysis using chest computed tomography and current AI applications in sarcoidosis. Morgenthau has published on high-resolution CT phenotypes in pulmonary sarcoidosis and the utility of positron-emission tomography (PET) and cardiac magnetic resonance (CMR) in assessing pulmonary hypertension and cardiac outcomes in sarcoidosis patients. His recent publications also explore the association of myocardial inflammation and fibrosis with adverse events in cardiac sarcoidosis, as well as the role of right atrial mass as a manifestation of the disease. He has also investigated the use of electrophysiologic testing for sudden death risk stratification in cardiac sarcoidosis patients with impaired left ventricular function. Morgenthau's scholarship metrics include an h-index of 13 and over 2,000 citations across 29 publications.
Metrics
- h-index: 13
- Publications: 29
- Citations: 2,037
Selected Publications
-
The Varying Histology of Hepatic Sarcoidosis and the Relation of Bile Duct Damage and Loss to the Presence of Portal Hypertension and Cirrhosis (2024)
Collaboration Network
Top Collaborators
- Pulmonary Artery 18F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis
- Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis
- Specific locations of myocardial inflammation and fibrosis are associated with higher risk of events in cardiac sarcoidosis
- Right Atrial Mass as Manifestation of Sarcoidosis
- Pulmonary Artery 18F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis
- Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis
- Specific locations of myocardial inflammation and fibrosis are associated with higher risk of events in cardiac sarcoidosis
- Pulmonary Artery 18F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis
- Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis
- Specific locations of myocardial inflammation and fibrosis are associated with higher risk of events in cardiac sarcoidosis
- Pulmonary Artery 18F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis
- Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis
- Specific locations of myocardial inflammation and fibrosis are associated with higher risk of events in cardiac sarcoidosis
- Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis
- Specific locations of myocardial inflammation and fibrosis are associated with higher risk of events in cardiac sarcoidosis
- Utility of electrophysiologic testing for sudden death risk stratification in cardiac sarcoidosis patients with mildly impaired left ventricular function
- Artificial Intelligence for Interstitial Lung Disease Analysis on Chest Computed Tomography: A Systematic Review
- Current Applications of Artificial Intelligence in Sarcoidosis
- Artificial Intelligence for Interstitial Lung Disease Analysis on Chest Computed Tomography: A Systematic Review
- Current Applications of Artificial Intelligence in Sarcoidosis
- Pulmonary Artery 18F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis
- Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis
- Pulmonary Artery 18F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis
- Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis
- Pulmonary Artery 18F-Fluorodeoxyglucose Uptake by PET/CMR as a Marker of Pulmonary Hypertension in Sarcoidosis
- Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis
- Utility of electrophysiologic testing for sudden death risk stratification in cardiac sarcoidosis patients with mildly impaired left ventricular function
- Abnormal Features of Cardiac MRI Associated with Non-Induciblity of Ventricular Arrhythmias in Cardiac Sarcoidosis Patients with Mildly Impaired Left Ventricular Ejection Fraction
- Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis
- Specific locations of myocardial inflammation and fibrosis are associated with higher risk of events in cardiac sarcoidosis
- Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis
- Specific locations of myocardial inflammation and fibrosis are associated with higher risk of events in cardiac sarcoidosis
- Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis
- Specific locations of myocardial inflammation and fibrosis are associated with higher risk of events in cardiac sarcoidosis
- Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis
- Specific locations of myocardial inflammation and fibrosis are associated with higher risk of events in cardiac sarcoidosis
Similar Researchers
Based on overlapping research topics